Bioavailability and Effect of Food on TAK-385 Tablet Formulations in Healthy Participants
NCT02396147
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
54
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Volunteers
Interventions
DRUG:
TAK-385 T2 Formulation
DRUG:
TAK-385 T4 Formulation B
DRUG:
TAK-385 T4 Formulation C
Sponsor
Takeda